NRC News and Press, National Research Corporation From 02/15/23

National Research Corporation (NRC) Q4 2022 Earnings Conference Call February 15, 2023, 11:00 am ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants George D'Angelo - Alpine Peaks Capital Presentation O...

National Research press release ( NASDAQ: NRC ): Q4 GAAP EPS of $0.27. Revenue of $38.14M (-0.4% Y/Y). For further details see: National Research GAAP EPS of $0.27, revenue of $38.14M

LINCOLN, Neb., Feb. 14, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter and calendar year 2022. Regarding the Company’s 2022 annual performance, Kevin Karas, Chief Financial Officer, said, “We ...

MALVERN, Pa., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a healthc...

Summary Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. The results for the typical investor in 2022 were likely worse still as many investors (including Wedgewood) had a meaningful we...

LINCOLN, Neb., Feb. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding® through personalized healthcare solutions and data-driven insights, has received the Best in KLAS 2023 Award for Patient Experience Improvement. The recognitio...

National Research ( NASDAQ: NRC ) declares $0.12/share quarterly dividend , in line with previous. Forward yield 1.04% Payable April 14; for shareholders of record March 31; ex-div March 30. See NRC Dividend Scorecard, Yield Chart, & Dividend Growth. For ...

Lincoln, Nebraska, Jan. 30, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 fourth quarter earnings conference call on Wednesday, February 15, 2023. The Company’s results for the 2023 fourth ...

MALVERN, Pa. and TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders (“...

MALVERN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the grantin...